Pharvaris N.V.
PHVS
$32.94
$1.695.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 36.05% | -5.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.49% | 1.20% | |||
| Operating Income | -19.49% | -1.20% | |||
| Income Before Tax | -20.27% | 15.10% | |||
| Income Tax Expenses | 1,012.82% | -192.22% | |||
| Earnings from Continuing Operations | -25.32% | 15.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.32% | 15.89% | |||
| EBIT | -19.49% | -1.20% | |||
| EBITDA | -19.51% | -1.20% | |||
| EPS Basic | -19.80% | 26.11% | |||
| Normalized Basic EPS | -14.98% | 25.42% | |||
| EPS Diluted | -19.80% | 26.11% | |||
| Normalized Diluted EPS | -14.98% | 25.42% | |||
| Average Basic Shares Outstanding | 4.60% | 13.84% | |||
| Average Diluted Shares Outstanding | 4.60% | 13.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||